Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120140290111550
Journal of Korean Medical Science
2014 Volume.29 No. 11 p.1550 ~ p.1554
Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
Park Se-Jin

Pai Ki-Soo
Kim Jun-Mo
Park Kwan-Jin
Kim Kun-Suk
Song Sang-Hoon
Park Sung-Chan
Kim Sun-Ouck
Ryu Dong-Soo
Baek Min-Ki
Lee Sang-Don
Lee Jung-Won
Im Young-Jae
Han Sang-Won
Chung Jae-Min
Cho Min-Hyun
Ha Tae-Sun
Cho Won-Yeol
Suh Hong-Jin
Abstract
We investigated the efficacy and tolerability of various anticholinergics in Korean children with non-neurogenic overactive bladder (OAB). A total of 326 children (males:females= 157:169) aged under 18 yr (mean age 7.3¡¾2.6 yr) who were diagnosed with OAB from 2008 to 2011 were retrospectively reviewed. The mean duration of OAB symptoms before anticholinergic treatment was 16.9¡¾19.0 months. The mean duration of medication was 5.6¡¾7.3 months. Urgency urinary incontinence episodes per week decreased from 1.9¡¾3.1 to 0.4¡¾1.5 times (P<0.001). The median voiding frequency during daytime was decreased from 9.2¡¾5.4 to 6.3¡¾4.2 times (P<0.001). According to 3-day voiding diaries, the maximum and average bladder capacity were increased from 145.5¡¾66.9 to 196.8¡¾80.3 mL and from 80.8¡¾39.6 to 121.8¡¾56.5 mL, respectively (P<0.001). On uroflowmetry, maximum flow rate was increased from 17.6¡¾8.4 to 20.5¡¾8.2 mL/sec (P<0.001). Adverse effects were reported in 14 (4.3%) children and six children (1.8%) discontinued medication due to adverse effects. Our results indicate that anticholinergics are effective to improve OAB symptoms and tolerability was acceptable without severe complications in children.
KEYWORD
Overactive Urinary Bladder, Urinary Incontinence, Anticholinergics, Efficacy, Tolerability
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø